FEBS Journals

Excellence in Bioscience Publishing From The Federation of European Biochemical Societies

Discover the FEBS journals today!

• View FREE sample issues • Read the top cited articles • Read the top accessed articles • Sign up for FREE Content Alerting

Editor-in-Chief: Seamus Martin Editorial office: Cambridge, UK

The FEBS Journal is an international journal devoted to the rapid publication of full-length papers and reviews covering a broad spectrum of topics in the molecular life sciences.

The FEBS Journal publishes in many areas including, but not limited to, structural biology, cell and molecular biology, immunology, bioinformatics, systems biology, genomics and proteomics, chemical biology, and the molecular basis of disease.

The FEBS Journal offers authors: • Distinguished international Editorial Board

• High visibility of published papers

• Fast and helpful peer review

• Open Access option

• No page charges and free colour figures

• Time to first decision normally less than 30 days

• Immediate free access to Reviews and Minireviews • The FEBS Journal Prize for Young Scientists

Special Issues Frontiers in Cell Signalling, and Ca2+ Signalling and Transport in Health and Disease Myogenesis Catalytic Mechanisms by Biological Systems Proteoglycans: Signaling, Targeting and Therapeutics Read these and more at www.febsjournal.org

Enzyme Catalysis and Allostery: A Century of Advances in Molecular Understanding Vol 281, Issue 2 (January 2014) Edited by Athel Cornish-Bowden

Virtual Issues MicroRNA

Epigenetics

Systems Biology

November 2013

Structural Biology

Edited by Pura Muñoz-Cánoves

Molecular Enzymology Read these and more at www.febsjournal.org

Keep up to date: • Sign up for content alerts

• Read the most read articles

• Read the latest articles published

• Read the current sample copy

• Read the most cited articles

www.febsjournal.org

Editor-in-Chief: J.E. Celis Editorial office: Copenhagen, Denmark

Molecular Oncology highlights new discoveries, approaches, as well as technical developments, in basic, clinical and discovery-driven translational research. A main feature of the journal is to provide an international forum for debating cancer issues, and for integrating the input of all the stakeholders.

Molecular Oncology offers authors: • No page charges and free colour • Fast review time, less than 3 weeks • Accepted articles published online within 5 days, to deliver your work to its audience as quickly as possible

• Comprehensive and constructive advice for improvements to papers • Fully automated submission system, allowing you to track the progress of your paper • Open Access options

• Connection with an audience of global cancer experts and stakeholders

Special Issues Critical issues on biomarkers discovery and validation

Published Special Issues

Edited by Alan Spatz and Leon van Kempen

Mouse models of cancer: Essential tools for better therapies

Drug resistance in cancer

Volume 7, Issue 2 (April 2013)

Edited by Daniel Peeper

Edited by Mariano Barbacid and Anton Berns

Innovative clinical trials for development of personalized cancer medicine Edited by Ulrik Ringborg, Richard Schilsky, and John Mendelsohn

Keep up to date: • Sign up for content alerts

• Read the most read articles

• Read the latest articles published

• Read the open archive articles

• Read the most cited articles

www.elsevier.com/locate/molonc

Executive Editor: Mary Purton Editorial office: Cambridge, UK

FEBS Open Bio is an online-only Open Access journal for the rapid publication of research articles in molecular and cellular life sciences in both health and disease. The journal’s peer review process focuses on the technical soundness of papers, leaving the assessment of their impact and importance to the scientific community.

FEBS Open Bio offers authors: • Easy online manuscript submission and tracking system

• All articles deposited in PubMed Central and indexed in PubMed

• Fast and helpful peer review – median time to first decision 23 days in 2013

• HTML enhancements, including 3D molecular viewer

• Transfer service for articles from other FEBS journals, conserving peer reviews

• Rapid, single article publication

• Open Access publication • A choice of Creative Commons licenses

Keep up to date: • Sign up for content alerts

• Read the most cited articles

• Read the latest articles published

• Read the most read articles

www.elsevier.com/locate/febsopenbio

Managing Editor: Felix Wieland Editorial office: Heidelberg, Germany

FEBS Letters is a world-renowned journal for the rapid publication of short reports describing novel and specific effects with a biologically or biochemically significant function. Bringing together the most important developments in the molecular biosciences, FEBS Letters provides an international forum with high-quality Reviews on cutting-edge science, in addition to Research Letters and Hypotheses of broad interest.

FEBS Letters offers authors: • Competent manuscript reviewing

• Special Issues

• Easy online submission system

• Fast-track manuscript handling

• No page charges and free colour figures

• Young Group Leader Award and Scientist Award

• Open Access options

Special Issues

Published Special Issues

Tumor Suppressors

Junctional Proteins

Edited by Shairaz Baksh, Giovanni Blandino and Wilhelm Just

Volume 588, Issue 8, April 2014

Gut Microbiome Edited by Lloyd Kasper and Wilhelm Just

Single Molecule Fluorescence Edited by Elias Puchner, Bo Huang and Herman Gaub

FEBS Congress, Paris Special Issue

Edited by Michael Koval, Brant Isakson, Rob Gourdie and Wilhelm Just Protein Engineering Volume 588, Issue 2, January 2014 Edited by Wilhelm Just

Edited by Wilhelm Just

Keep up to date: • Sign up for content alerts

• Read the most read articles

• Read the latest articles published

• Read the open archive articles

• Read the most cited articles

www.elsevier.com/locate/febslet

The Latest Results and Discussions Across the Molecular Life Sciences • Esteemed international Editorial Boards • High-quality peer review • Research articles, reviews, Special Issues, Virtual Issues and more • Fast publication • Innovative features including database linking, structured digital abstracts, enhanced html access and podcasts • Highly cited and highly accessed content • Open Access options

FEBS is a charitable organization advancing research in the molecular life sciences across Europe and beyond.

The publications are wholly owned by FEBS, and income from them funds FEBS programmes such as fellowships and courses.

FEBS is celebrating its 50th anniversary in 2014. Find out more at www.febs.org

• The FEBS Journal Prize • FEBS Letters Award

bit.ly/FEBSJprize

bit.ly/FEBSLprize

14-66344

Awards for Outstanding Papers – Read all about it!